{"id":3679,"date":"2026-08-27T18:06:33","date_gmt":"2026-08-27T18:06:33","guid":{"rendered":"https:\/\/indiamedicine.org\/?p=3679"},"modified":"2026-08-27T18:08:47","modified_gmt":"2026-08-27T18:08:47","slug":"cdsco-flags-280-drug-batches-substandard-august-2026","status":"publish","type":"post","link":"https:\/\/indiamedicine.org\/?p=3679","title":{"rendered":"CDSCO Flags 280 Drug Batches Substandard in August 2026 Sweep"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">India&#8217;s Central Drugs Standard Control Organisation (CDSCO) has flagged approximately 280 drug batches as Not of Standard Quality (NSQ) in its latest quality surveillance sweep, according to reports in <strong>The Economic Times<\/strong> (August 21, 2026). The finding underscores the regulator&#8217;s ongoing post-market quality monitoring efforts across India&#8217;s pharmaceutical manufacturing landscape.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1F4CA; What the CDSCO Quality Alert Covers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The CDSCO&#8217;s quality control framework routinely tests drug samples drawn from manufacturing facilities, wholesale distributors, and retail outlets across India. The August 2026 sweep identified 280 batches that failed to meet established standards for identity, purity, potency, dissolution, or sterility \u2014 depending on the dosage form.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Multiple formulations were affected, including commonly prescribed antibiotics, cardiovascular drugs, and other therapeutic categories. One batch was specifically flagged as <strong>spurious<\/strong> \u2014 a designation reserved for products that are deliberately counterfeit or adulterated, representing the most serious category of quality violation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">&#x2699;&#xFE0F; How CDSCO Quality Surveillance Works<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CDSCO&#8217;s quality surveillance operates through a multi-layered system:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sample collection:<\/strong> Drug samples are collected from manufacturing sites, distribution channels, and retail pharmacies across states.<\/li>\n<li><strong>Laboratory testing:<\/strong> Samples are tested against Indian Pharmacopoeia (IP) standards at CDSCO-accredited laboratories and state drug control laboratories.<\/li>\n<li><strong>NSQ classification:<\/strong> Batches that fail testing are classified as Not of Standard Quality (NSQ), spurious, or misbranded depending on the nature of the violation.<\/li>\n<li><strong>Public notification:<\/strong> Flagged batches are published in official CDSCO notifications, enabling regulators, manufacturers, and the public to identify affected products.<\/li>\n<li><strong>Enforcement action:<\/strong> Manufacturers of substandard or spurious drugs face show cause notices, product recalls, manufacturing suspension, prosecution, and in severe cases, cancellation of manufacturing licenses.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1F50D; Why This Matters for Generic Medicine Buyers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">For international buyers sourcing Indian generic medicines \u2014 whether hospitals, pharmacies, procurement agencies, or individual patients \u2014 CDSCO quality alerts provide an important signal about the regulatory environment in which their suppliers operate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A regulator that actively tests, flags, and publicizes substandard products is a positive sign \u2014 it means the enforcement infrastructure exists and is functioning. But it also means that any individual batch or manufacturer may be subject to quality failures, and buyers should not assume that all products from all Indian manufacturers are of uniform quality.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">&#x2705; What Buyers Should Verify Before Sourcing<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Based on CDSCO&#8217;s current regulatory framework and quality surveillance actions observed in 2026, international buyers should verify the following before purchasing Indian generic medicines:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>CDSCO manufacturing approval (MA number):<\/strong> Confirm the specific drug, strength, and manufacturer holds a current CDSCO manufacturing approval.<\/li>\n<li><strong>WHO-GMP certification:<\/strong> Verify the manufacturing facility holds WHO-GMP certification, and where relevant, USFDA or EMA facility approvals.<\/li>\n<li><strong>Batch Certificate of Analysis (CoA):<\/strong> Request a valid CoA from an accredited laboratory for each batch being purchased.<\/li>\n<li><strong>Manufacturer enforcement history:<\/strong> Check whether the manufacturer has appeared in CDSCO NSQ notifications, USFDA import alerts, or WHO prequalification delisting actions.<\/li>\n<li><strong>FDC ban status:<\/strong> If sourcing a fixed-dose combination product, confirm it has not been banned under the Drugs and Cosmetics Act.<\/li>\n<li><strong>Destination country import rules:<\/strong> Verify the product meets the import requirements of the destination country.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1F6A8; Red Flags to Watch For<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When sourcing Indian generic medicines, be alert to these warning signs:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Prices significantly below market average \u2014 extreme discounts can signal substandard quality or grey-market sourcing.<\/li>\n<li>Manufacturers unable to provide CDSCO approval documentation, batch CoAs, or bioequivalence reports.<\/li>\n<li>Products labelled &#8220;not for export&#8221; or India-market-only being offered for international sale.<\/li>\n<li>Absence of WHO-GMP or equivalent quality certification for the manufacturing facility.<\/li>\n<li>No verifiable contact information or regulatory compliance documentation from the distributor.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1F517; Where to Find Verified Suppliers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">For buyers seeking reliable pharmaceutical distributors, <strong>IMSDA&#8217;s verified member directory<\/strong> provides a starting point for identifying trusted suppliers. For a list of verified and reliable pharmaceutical distributors, refer to the <a href=\"https:\/\/indiamedicine.org\/?page_id=1454\">IMSDA&#8217;s verified member directory<\/a>.<\/p>\n\n\n\n<hr class=\"wp-block-separator\" \/>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Source: The Economic Times (August 21, 2026) \u2014 CDSCO flags 280 drug batches including one spurious sample in August 2026 quality tests.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For more information, contact IMSDA at contact@indiamedicine.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>India&#8217;s Central Drugs Standard Control Organisation (CDSCO) has flagged approximately 280 drug batches as Not of Standard Quality (NSQ) in its latest quality surveillance sweep, according to reports in The Economic Times (August 21, 2026). The finding underscores the regulator&#8217;s ongoing post-market quality monitoring efforts across India&#8217;s pharmaceutical manufacturing landscape. &#x1F4CA; What the CDSCO Quality [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[42,48,49],"class_list":["post-3679","post","type-post","status-publish","format-standard","hentry","category-news","tag-cdsco","tag-generic-medicines","tag-indian-pharma","entry"],"_links":{"self":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3679"}],"version-history":[{"count":1,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3679\/revisions"}],"predecessor-version":[{"id":3680,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3679\/revisions\/3680"}],"wp:attachment":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}